Illumina stock skidded Tuesday after China signaled it would ban the company from importing its gene-mapping products.

Cramer looks at Illumina, Archer Aviation, NANO Nuclear Energy, Steris, Sixth Street Specialty Lending, Lam Research and ...

Shares of Illumina (NASDAQ: ILMN) were falling on Friday. The company's stock was down by as much as 11.4% early in the session, and was still off by 8.7% as of 2:38 p.m. ET. At that time ...

The stock dropped roughly 5.5% Tuesday morning. ↘️ Delta Air Lines (DAL): The carrier cut its outlook, as did American Airlines (AAL) and JetBlue (JBLU). Illumina is reducing its forecast for ...

The stock's rise snapped a four-day losing streak.

That morning, Barclays changed its recommendation on Illumina stock to underweight (read: sell) from the previous equal weight (hold). It also pulled the lever on a significant price target ...

In a report released today, Canaccord Genuity also maintained a Hold rating on the stock with a $115.00 price target. Based on Illumina’s latest earnings release for the quarter ending December ...

Current RSI values indicate that the stock is may be oversold. Next earnings report is scheduled for 51 days from now. Professional Analyst Ratings for Illumina In the last month, 5 experts ...

Brown Advisors, an investment management company, released its “Brown Advisors Global Leaders Strategy” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.